Clinical Trial Update: The Effects of Mesenchymal Stem Cell Secretome in Rheumatoid Arthritis Patients [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating the effects of mesenchymal stem cell secretome in patients with rheumatoid arthritis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Mesenchymal stem cell secretome

Snippet

Sponsor: Universitas Sebelas Maret | Conditions: Rheumatoid Arthritis | Phase 1, Phase 2 | Status: COMPLETED